Beachbody Co., Inc. Class A BODI 深 滬
已收盤 05-08 16:00:00 美东时间
13.61
-0.460
-3.27%
華盛通- 最 高14.20
- 今 開14.20
- 成交量 7.21万股
- 最 低 13.06
- 昨 收 14.07
- 總市值 9847.06万
- 52周最高 16.87
- 市盈率 靜 --
- 換手率 1.00%
- 52周最低 3.3812
- 委 比 -69.49%
- 總股本 723.52万
- 歷史最高 910.00
- 量 比 0.97
- 振 幅 8.10%
- 歷史最低 3.3812
- 每 手 1
- 風險率 3.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
Canaccord Genuity Maintains Buy on Beachbody Co, Raises Price Target to $19
Canaccord Genuity analyst Susan Anderson maintains Beachbody Co (NASDAQ:BODI) with a Buy and raises the price target from $15 to $19.
05-06 02:45
Shares of companies within the broader consumer discretionary sector are trading higher amid overall market strength after Iran opened the Strait of Hormuz for the remainder of the ceasefire following a 10-day armistice between Israel and Lebanon. This alleviates the ongoing supply disruption and lessens energy costs.
Shares of companies within the broader consumer discretionary sector are tradin...
04-18 01:13
Shares of companies within the broader consumer discretionary sector are trading lower as spiking energy costs and inflation may limit nonessential spending.
Shares of companies within the broader consumer discretionary sector are tradin...
03-28 03:41
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
美股大行评级 | 潜在涨幅467.73%！Corbus制药控股获Oppenheimer升目标价至57美元，维持"跑赢大市"评级
今日重点评级关注：Oppenheimer：维持Corbus制药控股"跑赢大市"评级，目标价从53美元升至57美元；Canaccord Genuity：维持WAVE Life Sciences"买入"评级，目标价从43美元升至52美元
03-11 12:40
Beachbody Co Sees Q1 Sales $49.000M-$54.000M vs $52.572M Est
Beachbody Co (NYSE:BODI) sees Q1 sales of $49.000 million-$54.000 million vs $52.572 million analyst estimate.
03-11 04:10
Beachbody Co Earnings Review: Q4 Summary
Beachbody Co (NASDAQ:BODI) released its Q4 earnings on Tuesday, March 10, 2026 ...
03-11 04:10
Canaccord Genuity Maintains Buy on Beachbody Co, Raises Price Target to $12
Canaccord Genuity analyst Susan Anderson maintains Beachbody Co (NASDAQ:BODI) with a Buy and raises the price target from $9 to $12.
03-11 00:06
Earnings Scheduled For March 10, 2026
Companies Reporting Before The Bell • Ultralife (NASDAQ:ULBI) is likely to repo...
03-10 19:11
